Select Options
- Indorama Ventures in its joint-venture acquisition of polyethylene terephthalate (PET) and purified terephthalic acid (PTA) assets from M&G Chemicals
- Liberty Media and SiriusXM in numerous transactions, including the acquisition of Pandora Media
- Novartis in its proposed sale of generic pharmaceutical assets to Aurobindo
- Liberty Expedia in its proposed merger with Expedia
- Celgene Corporation in its acquisition of Juno Therapeutics
- Liberty Interactive and QVC in the acquisition of Home Shopping Network (HSN)
- Halliburton in its proposed acquisition of Baker Hughes
- Boehringer Ingelheim in its asset swap with Sanofi and related divestiture of animal health assets to Eli Lilly
- Merck & Co., Inc. in various acquisitions and potential acquisitions
- American Industrial Partners in its acquisition of Flow International
- Liberty Interactive in the its sale of Proflowers.com to FTD
- A leading pharmaceutical company in a worldwide research, development, and commercialization collaboration
- Harold Levinson Associates in an antitrust action involving Robinson-Patman Act claims brought by Satnam Distributors
- Counseled numerous companies through the merger process, including evaluating the necessity of HSR filings, analyzing risk of government investigations, and responding to government inquiries